Literature DB >> 7966205

Characterisation of pathogenic Yersinia enterocolitica serogroups by pulsed-field gel electrophoresis of genomic NotI restriction fragments.

E Saken1, A Roggenkamp, S Aleksic, J Heesemann.   

Abstract

Enteropathogenic Yersinia enterocolitica is an important cause of human and animal disease. Phenotypic and genotypic characteristics currently used to identify Y. enterocolitica are not necessarily sufficient to differentiate pathogenic from non-pathogenic strains or to analyse the epidemiology of yersiniae at a molecular level. To improve the characterisation of Yersinia isolates, NotI restriction fragment length polymorphisms (RFLPs) of chromosomal DNA of more than 100 clinical, animal and environmental isolates were analysed in pulsed-field gel electrophoresis. Highly conserved RFLP patterns with fragments ranging from 15 to 400 kb were detected within each of 10 Y. enterocolitica serogroups tested. Determination of RFLP types makes it possible to discriminate between isolates of different Y. enterocolitica serogroups and other Yersinia spp. Moreover, NotI restriction endonuclease analysis allows even subtyping of strains belonging to a unique serogroup-biotype. Identification of NotI fragments hybridising with inv- or ail-homologous sequences was used as an additional discriminating marker. The results indicate that NotI RFLP typing can provide a powerful new tool for the differentiation of clinical Y. enterocolitica isolates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7966205     DOI: 10.1099/00222615-41-5-329

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Application of fluorescent amplified fragment length polymorphism for comparison of human and animal isolates of Yersinia enterocolitica.

Authors:  Catherine Fearnley; Stephen L W On; Branko Kokotovic; Georgina Manning; Tom Cheasty; Diane G Newell
Journal:  Appl Environ Microbiol       Date:  2005-09       Impact factor: 4.792

2.  Molecular characterization of human clinical isolates of Yersinia enterocolitica bioserotype 1B/O8 in Poland: emergence and dissemination of three highly related clones.

Authors:  Rafał Gierczyñski; Jolanta Szych; Waldemar Rastawicki; Sebastian Wardak; Marek Jagielski
Journal:  J Clin Microbiol       Date:  2009-02-09       Impact factor: 5.948

3.  Discriminatory power and application of ribotyping of Yersinia enterocolitica O:3 in an epidemiological study.

Authors:  M C Mendoza; R Alzugaray; E Landeras; M A González-Hevia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-03       Impact factor: 3.267

4.  Bacteriological and serological findings in a further case of transfusion-mediated Yersinia enterocolitica sepsis.

Authors:  E Strobel; J Heesemann; G Mayer; J Peters; S Müller-Weihrich; P Emmerling
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

5.  Identification and characterization of pathogenic Yersinia enterocolitica isolates by PCR and pulsed-field gel electrophoresis.

Authors:  S Thisted Lambertz; M-L Danielsson-Tham
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

6.  Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen.

Authors:  A Roggenkamp; A M Geiger; L Leitritz; A Kessler; J Heesemann
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Ferric enterochelin transport in Yersinia enterocolitica: molecular and evolutionary aspects.

Authors:  S Schubert; D Fischer; J Heesemann
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

8.  Multilocus variable-number tandem-repeat analysis, pulsed-field gel electrophoresis, and antimicrobial susceptibility patterns in discrimination of sporadic and outbreak-related strains of Yersinia enterocolitica.

Authors:  Leila M Sihvonen; Susanna Toivonen; Kaisa Haukka; Markku Kuusi; Mikael Skurnik; Anja Siitonen
Journal:  BMC Microbiol       Date:  2011-02-25       Impact factor: 3.605

9.  Yersinia enterocolitica palearctica serobiotype O:3/4--a successful group of emerging zoonotic pathogens.

Authors:  Julia Batzilla; Uladzimir Antonenka; Dirk Höper; Jürgen Heesemann; Alexander Rakin
Journal:  BMC Genomics       Date:  2011-07-06       Impact factor: 3.969

10.  Yersinia enterocolitica: Epidemiological Studies and Outbreaks.

Authors:  Atiqur Rahman; Tania S Bonny; Siriporn Stonsaovapak; Chiraporn Ananchaipattana
Journal:  J Pathog       Date:  2011-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.